Plain-English translation of NCT05331144 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
The IPAT study is testing whether keeping blood pressure very low (below 120) can help protect the brain from changes that lead to memory problems and dementia. Researchers will compare two groups: people who take medication to lower their blood pressure intensively versus those who follow their regular doctor's recommendations. The study uses brain imaging and memory tests to see if the medication has protective effects.
High blood pressure may damage the brain in ways that lead to dementia, but we don't know if aggressively treating it can prevent this damage. This study will help doctors understand whether pushing blood pressure lower than we typically do might protect memory and thinking in older adults.
If you join, you'll be randomly assigned to either take medication to lower your blood pressure very aggressively or to follow your regular doctor's recommendations. You'll visit the clinic for check-ups, blood pressure monitoring, and brain imaging scans (MRI) over 24 months. You'll also complete memory and thinking tests to help researchers understand if the treatment is protecting your brain.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
United States